Issue Date: January 23, 2012
Japan’s Takeda Sheds Jobs In U.S., Europe
Following its September 2011 acquisition of the Swiss drugmaker Nycomed, Takeda Pharmaceutical is embarking on a restructuring program that will cut 2,800 jobs, or 9% of its workforce, across R&D, commercial, operations, and administrative functions. About 2,100 of the jobs to be eliminated are in Europe, and the balance are in the U.S. The Japanese company says it will also consolidate R&D and other sites across the globe. Takeda expects the plan to cost more than $900 million through 2015 but save $2.6 billion.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society